MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis
Business Wire India MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease…
